Amgen (NASDAQ: AMGN) posted better-than-expected FQ4 profit, while revenue growth fell short of consensus estimates and product revenue fell 1 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE